Please login to the form below
emerging markets
This page shows the latest emerging markets news and features for those working in and with pharma, biotech and healthcare.
Takeda to sell Japan consumer health unit for $2.3bn
This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.
Latest news
-
AstraZeneca’s Farxiga scores another FDA fast-track designation
That’s an increase of 14% at a constant exchange rate, thanks mostly to sales increases in emerging markets including China.
-
AstraZeneca’s Brilinta reduces rate of secondary stroke
Those indications helped the drug to deliver sales of $1.6bn in 2019, which constitutes a 23% growth over the year driven in particular by a strong performance in emerging markets.
-
AZ revenues rise, but it says coronavirus could hit 2020
Product sales were up 12% to $23.57bn for the full-year, driven by cancer products and turnover in emerging markets, although there was a bit of a slowdown to 8% ... Emerging market sales rose 18% to $2.09bn in the fourth quarter, accounting for a
-
Merck spins off low-growth drugs in a ‘purposeful shift’ of focus
His experience includes serving as president of MSD international and the company’s emerging markets unit, and he will be joined by Carrie Cox, ex-CEO of Humacyte, who will chair
-
Lynparza cleared for first-line ovarian cancer use in China
This approval in China, which is emerging as one of the fastest growing pharmaceutical markets in the world, consolidates Lynparza’s position as the runaway leader among PARP inhibitor treatments. ... increase in the US and a 227% increase in emerging
More from news
Approximately 13 fully matching, plus 353 partially matching documents found.
Latest Intelligence
-
Pharma funding and M&A in 2020
As we see with Takeda – and as we’ve seen with other industries, notably tech – companies from fast- growing emerging markets continue to rise.
-
BRIC markets
The idea was to illustrate the growing importance of emerging economies relative to developed markets and to encourage the G7 to factor them into policymaking. ... He added: “The hype about BRIC markets is cooler than it used to be.
-
The mission matters
Developed and emerging markets differ greatly but there are also great differences between developed markets, such as Europe and the US. ... And within markets, therapy areas differ hugely, ranging from rare diseases and oncology to primary care and
-
Leading AstraZeneca’s return to growth in Europe
Now the business has two particularly strong growth drivers: emerging markets, most especially China, and oncology, where a triumvirate of drugs – Tagrisso, Imfinzi and Lynparza – have hit a major growth phase. ... So does AstraZeneca believe there
-
It’s not the end of the world, is it?
the US market when they would, de facto, be barred from other developed and price-controlled markets. ... As emerging markets become richer, access to at least basic healthcare is one of the first developed market characteristics that their citizens seek
More from intelligence
Approximately 14 fully matching, plus 61 partially matching documents found.
Latest appointments
-
New faces at JPA Health Communications, GCI Health and HRW
Her more recent focus has been in conducting business in emerging markets. ... In the newly created global director role, Rees will focus on expanding the business across the company, as well as developing business opportunities in emerging markets.
-
Pfizer names Albert Bourla as COO
regional head for US vaccines, vice president for emerging markets for primary care and vice president of the US brands business within essential health.
-
Sobi appoints Torbjorn Hallberg as general counsel
Hallberg, who joins from Takeda, where he served for seven years, first as senior director and corporate counsel and then more recently as its vice president, general counsel for emerging markets.
-
Paolo Carli appointed as head of MEA at Merck
emerging markets.
-
Neovii Pharmaceuticals promotes Juergen Pohle to CEO
Prior to joining Neovii he headed up Novartis’ emerging growth markets and institutional customers businesses.
More from appointments
Approximately 0 fully matching, plus 35 partially matching documents found.
Latest from PMHub
-
Syndicated study
Maximising digital communications with physicians in China. We are currently conducting a syndicated study to assess the impact of COVID-19 on how Chinese doctors use digital channels to interact with pharma companies through interviews with 270
-
Article: Spotlight on Mexico
Healthcare under AMLO – One year on. In this article, Rachel Howard and local expert Dr Xavier Tello, discuss the latest changes in the healthcare system and consider what they mean for pharmaceutical manufacturers wishing to enter the Mexican
-
News: Mandira Kar joins London Headquarters as Qualitative Research Director
She has previously worked in a wide range of research industries including consumer and digital and has experience in many global markets, especially emerging markets, having lived and worked for a
-
Article: Market access in Brazil
All eyes on Spinraza. Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil? In April 2019, Brazilian Health Minister Luiz Henrique
-
China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region. Download
More from PMHub
Approximately 67 fully matching, plus 39 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
